nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomethadyl Acetate—CYP19A1—uterine cancer	0.615	1	CbGaD
Levomethadyl Acetate—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0881	0.248	CbGbCtD
Levomethadyl Acetate—CYP3A7—Progesterone—uterine cancer	0.0881	0.248	CbGbCtD
Levomethadyl Acetate—CYP3A5—Progesterone—uterine cancer	0.0661	0.186	CbGbCtD
Levomethadyl Acetate—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0389	0.109	CbGbCtD
Levomethadyl Acetate—CYP3A5—Etoposide—uterine cancer	0.0296	0.0831	CbGbCtD
Levomethadyl Acetate—CYP3A4—Progesterone—uterine cancer	0.0258	0.0724	CbGbCtD
Levomethadyl Acetate—CYP3A4—Etoposide—uterine cancer	0.0115	0.0324	CbGbCtD
Levomethadyl Acetate—CYP19A1—corpus luteum—uterine cancer	0.00959	0.476	CbGeAlD
Levomethadyl Acetate—CYP3A4—Doxorubicin—uterine cancer	0.00787	0.0221	CbGbCtD
Levomethadyl Acetate—CYP19A1—semen—uterine cancer	0.00449	0.223	CbGeAlD
Levomethadyl Acetate—CYP19A1—endometrium—uterine cancer	0.000742	0.0368	CbGeAlD
Levomethadyl Acetate—CHRNA3—lymph node—uterine cancer	0.000702	0.0348	CbGeAlD
Levomethadyl Acetate—CYP19A1—uterus—uterine cancer	0.000684	0.0339	CbGeAlD
Levomethadyl Acetate—CYP19A1—female reproductive system—uterine cancer	0.000614	0.0305	CbGeAlD
Levomethadyl Acetate—CYP19A1—female gonad—uterine cancer	0.000559	0.0277	CbGeAlD
Levomethadyl Acetate—CYP3A5—uterine cervix—uterine cancer	0.00053	0.0263	CbGeAlD
Levomethadyl Acetate—CYP3A5—renal system—uterine cancer	0.000496	0.0246	CbGeAlD
Levomethadyl Acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.000478	0.0586	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—renal system—uterine cancer	0.000372	0.0185	CbGeAlD
Levomethadyl Acetate—CYP3A5—female gonad—uterine cancer	0.000361	0.0179	CbGeAlD
Levomethadyl Acetate—CYP19A1—lymph node—uterine cancer	0.000359	0.0178	CbGeAlD
Levomethadyl Acetate—CYP3A5—vagina—uterine cancer	0.000359	0.0178	CbGeAlD
Levomethadyl Acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.000345	0.0424	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.000345	0.0424	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—female reproductive system—uterine cancer	0.000298	0.0148	CbGeAlD
Levomethadyl Acetate—Tamoxifen—ESR2—uterine cancer	0.000293	0.339	CrCbGaD
Levomethadyl Acetate—CYP19A1—Endogenous sterols—CYP11A1—uterine cancer	0.000276	0.0338	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.000209	0.0257	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.000207	0.0253	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Ovarian Infertility Genes—MLH1—uterine cancer	0.000206	0.0252	CbGpPWpGaD
Levomethadyl Acetate—Tamoxifen—CYP19A1—uterine cancer	0.000196	0.227	CrCbGaD
Levomethadyl Acetate—CYP19A1—Ovarian Infertility Genes—PGR—uterine cancer	0.000195	0.0239	CbGpPWpGaD
Levomethadyl Acetate—Methadone—CYP19A1—uterine cancer	0.000195	0.225	CrCbGaD
Levomethadyl Acetate—Tamoxifen—ESR1—uterine cancer	0.000181	0.209	CrCbGaD
Levomethadyl Acetate—CYP19A1—Ovarian Infertility Genes—ESR2—uterine cancer	0.000172	0.021	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.000161	0.0197	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—ABCC9—uterine cancer	0.000135	0.0166	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000128	0.0157	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Ovarian Infertility Genes—SMAD3—uterine cancer	0.000128	0.0156	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000126	0.0155	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—ABCC9—uterine cancer	0.000123	0.0151	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—IL4-mediated signaling events—HMGA1—uterine cancer	0.000116	0.0142	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—YWHAE—uterine cancer	0.000113	0.0138	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000111	0.0136	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00011	0.0135	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—ESR2—uterine cancer	0.000104	0.0128	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000104	0.0127	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—AKR1B10—uterine cancer	9.78e-05	0.012	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—AKR1B1—uterine cancer	9.09e-05	0.0112	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	9.02e-05	0.0111	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—IL4-mediated signaling events—SOCS3—uterine cancer	8.68e-05	0.0106	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—AKR1B10—uterine cancer	8.49e-05	0.0104	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	8.18e-05	0.01	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	8.13e-05	0.00997	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	8.08e-05	0.0099	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	8.04e-05	0.00986	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	7.94e-05	0.00973	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—AKR1B1—uterine cancer	7.9e-05	0.00968	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Ovarian Infertility Genes—CDKN1B—uterine cancer	7.08e-05	0.00868	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—AKR1C1—uterine cancer	6.67e-05	0.00818	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.63e-05	0.00814	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	6.59e-05	0.00809	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	6.52e-05	0.00799	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—AKR1B10—uterine cancer	6.14e-05	0.00753	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	5.92e-05	0.00725	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—GPX3—uterine cancer	5.86e-05	0.00719	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	5.84e-05	0.00716	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—AKR1C1—uterine cancer	5.8e-05	0.00711	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—AKR1B1—uterine cancer	5.71e-05	0.007	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—CYP11A1—uterine cancer	5.52e-05	0.00676	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—CYP11A1—uterine cancer	5.44e-05	0.00667	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—AKR1C3—uterine cancer	5.14e-05	0.0063	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—GPX3—uterine cancer	5.09e-05	0.00624	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.9e-05	0.00601	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	4.8e-05	0.00588	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—CYP11A1—uterine cancer	4.79e-05	0.00587	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—CYP11A1—uterine cancer	4.72e-05	0.00579	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—STK11—uterine cancer	4.5e-05	0.00552	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—AKR1C3—uterine cancer	4.46e-05	0.00547	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—CXCL8—uterine cancer	4.4e-05	0.00539	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—FSH signaling pathway—AKT1—uterine cancer	4.3e-05	0.00527	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—AKR1C1—uterine cancer	4.19e-05	0.00514	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	4.06e-05	0.00498	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—EP300—uterine cancer	3.77e-05	0.00463	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	3.74e-05	0.00458	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	3.69e-05	0.00452	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—GPX3—uterine cancer	3.68e-05	0.00451	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—VEGFA—uterine cancer	3.57e-05	0.00438	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.54e-05	0.00434	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.54e-05	0.00434	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—CYP19A1—uterine cancer	3.52e-05	0.00432	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—CYP19A1—uterine cancer	3.48e-05	0.00426	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—CYP11A1—uterine cancer	3.46e-05	0.00425	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—CYP11A1—uterine cancer	3.42e-05	0.00419	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	3.4e-05	0.00417	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—AKR1C3—uterine cancer	3.23e-05	0.00396	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	3.03e-05	0.00372	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—uterine cancer	3.01e-05	0.00369	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	2.85e-05	0.0035	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2.81e-05	0.00345	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	2.75e-05	0.00337	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—IL4-mediated signaling events—PIK3CA—uterine cancer	2.73e-05	0.00335	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	2.71e-05	0.00333	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	2.65e-05	0.00325	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	2.62e-05	0.00321	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.6e-05	0.00319	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	2.57e-05	0.00316	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	2.55e-05	0.00312	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	2.51e-05	0.00308	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—IL4-mediated signaling events—AKT1—uterine cancer	2.23e-05	0.00274	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	2.23e-05	0.00273	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCL2—uterine cancer	2.23e-05	0.00273	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—SRD5A2—uterine cancer	2.18e-05	0.00267	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—NDUFB11—uterine cancer	2.18e-05	0.00267	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.12e-05	0.0026	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—HRAS—uterine cancer	2.12e-05	0.0026	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2e-05	0.00245	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	1.95e-05	0.00239	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—HRAS—uterine cancer	1.94e-05	0.00237	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	1.93e-05	0.00237	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—SRD5A2—uterine cancer	1.89e-05	0.00232	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—NDUFB11—uterine cancer	1.89e-05	0.00232	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	1.88e-05	0.00231	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—HRAS—uterine cancer	1.88e-05	0.0023	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—EP300—uterine cancer	1.8e-05	0.0022	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—CXCL8—uterine cancer	1.76e-05	0.00216	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	1.71e-05	0.0021	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	1.7e-05	0.00209	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—AKT1—uterine cancer	1.66e-05	0.00203	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—HRAS—uterine cancer	1.62e-05	0.00199	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	1.61e-05	0.00197	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	1.59e-05	0.00195	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—STAR—uterine cancer	1.58e-05	0.00193	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—AKR1B1—uterine cancer	1.58e-05	0.00193	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	1.5e-05	0.00184	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	1.49e-05	0.00183	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—CXCL8—uterine cancer	1.48e-05	0.00182	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—HRAS—uterine cancer	1.48e-05	0.00182	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.45e-05	0.00177	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—AKR1B10—uterine cancer	1.43e-05	0.00176	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—STAR—uterine cancer	1.37e-05	0.00168	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—AKR1B1—uterine cancer	1.37e-05	0.00168	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—SRD5A2—uterine cancer	1.37e-05	0.00168	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NDUFB11—uterine cancer	1.37e-05	0.00168	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.29e-05	0.00158	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—POLD1—uterine cancer	1.24e-05	0.00152	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—RNF43—uterine cancer	1.19e-05	0.00145	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.18e-05	0.00145	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	1.18e-05	0.00145	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.17e-05	0.00143	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—AKR1C1—uterine cancer	1.16e-05	0.00142	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CCL2—uterine cancer	1.14e-05	0.00139	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.09e-05	0.00133	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—INHBA—uterine cancer	1.09e-05	0.00133	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—POLD1—uterine cancer	1.07e-05	0.00132	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—RRM2—uterine cancer	1.03e-05	0.00126	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—AKR1C1—uterine cancer	1e-05	0.00123	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—DCN—uterine cancer	1e-05	0.00123	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—AKR1B1—uterine cancer	9.9e-06	0.00121	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—STAR—uterine cancer	9.9e-06	0.00121	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—AKR1C1—uterine cancer	9.77e-06	0.0012	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CYP11A1—uterine cancer	9.43e-06	0.00116	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—CXCL8—uterine cancer	8.99e-06	0.0011	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—RRM2—uterine cancer	8.96e-06	0.0011	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—AKR1C3—uterine cancer	8.91e-06	0.00109	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—DCN—uterine cancer	8.7e-06	0.00107	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CYP11A1—uterine cancer	8.19e-06	0.001	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—POLD1—uterine cancer	7.77e-06	0.000952	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—AKR1C3—uterine cancer	7.74e-06	0.000949	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—AKR1C3—uterine cancer	7.52e-06	0.000922	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PGR—uterine cancer	7.33e-06	0.000899	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—AKR1C1—uterine cancer	7.26e-06	0.000891	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—YWHAE—uterine cancer	6.99e-06	0.000858	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—STK11—uterine cancer	6.94e-06	0.000851	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—FBXW7—uterine cancer	6.7e-06	0.000822	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.52e-06	0.000799	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—RRM2—uterine cancer	6.47e-06	0.000794	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NDUFB11—uterine cancer	6.36e-06	0.00078	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SRD5A2—uterine cancer	6.36e-06	0.00078	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—DCN—uterine cancer	6.29e-06	0.000771	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.21e-06	0.000762	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—STK11—uterine cancer	6.03e-06	0.000739	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CYP19A1—uterine cancer	6.03e-06	0.000739	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP11A1—uterine cancer	5.92e-06	0.000726	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—STK11—uterine cancer	5.86e-06	0.000719	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CCL2—uterine cancer	5.83e-06	0.000715	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—AKR1C3—uterine cancer	5.59e-06	0.000686	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SOCS3—uterine cancer	5.49e-06	0.000673	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CDKN2B—uterine cancer	5.25e-06	0.000644	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—MTHFR—uterine cancer	5.22e-06	0.00064	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IGF1R—uterine cancer	5.1e-06	0.000626	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—CXCL8—uterine cancer	5.08e-06	0.000623	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SMAD3—uterine cancer	4.8e-06	0.000588	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—CXCL8—uterine cancer	4.61e-06	0.000566	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—AKR1B1—uterine cancer	4.6e-06	0.000564	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—STAR—uterine cancer	4.6e-06	0.000564	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.6e-06	0.000564	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—FGFR2—uterine cancer	4.57e-06	0.000561	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—MTHFR—uterine cancer	4.53e-06	0.000555	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—STK11—uterine cancer	4.36e-06	0.000534	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP19A1—uterine cancer	4.36e-06	0.000534	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ESR1—uterine cancer	3.91e-06	0.00048	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—NRAS—uterine cancer	3.7e-06	0.000454	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—POLD1—uterine cancer	3.61e-06	0.000443	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CCL2—uterine cancer	3.45e-06	0.000423	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—AKR1C1—uterine cancer	3.38e-06	0.000414	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—MTHFR—uterine cancer	3.27e-06	0.000401	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—PIK3CA—uterine cancer	3.22e-06	0.000395	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—KRAS—uterine cancer	3.18e-06	0.00039	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—RRM2—uterine cancer	3.01e-06	0.000369	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PIK3CA—uterine cancer	2.93e-06	0.000359	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—DCN—uterine cancer	2.92e-06	0.000358	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PTEN—uterine cancer	2.9e-06	0.000356	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ERBB2—uterine cancer	2.87e-06	0.000352	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—EP300—uterine cancer	2.77e-06	0.000339	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.75e-06	0.000338	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CXCL8—uterine cancer	2.72e-06	0.000334	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—HRAS—uterine cancer	2.71e-06	0.000332	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CDKN1B—uterine cancer	2.66e-06	0.000326	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—AKT1—uterine cancer	2.63e-06	0.000323	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.6e-06	0.000319	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PTEN—uterine cancer	2.52e-06	0.000309	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CTNNB1—uterine cancer	2.51e-06	0.000308	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PTEN—uterine cancer	2.45e-06	0.0003	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—EP300—uterine cancer	2.4e-06	0.000295	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—AKT1—uterine cancer	2.39e-06	0.000293	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—EP300—uterine cancer	2.34e-06	0.000286	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—VEGFA—uterine cancer	2.21e-06	0.000271	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—NRAS—uterine cancer	2.19e-06	0.000268	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PIK3CA—uterine cancer	2.05e-06	0.000251	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.03e-06	0.000248	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—STK11—uterine cancer	2.03e-06	0.000248	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—KRAS—uterine cancer	1.88e-06	0.000231	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PTEN—uterine cancer	1.82e-06	0.000223	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PIK3CA—uterine cancer	1.78e-06	0.000218	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—EP300—uterine cancer	1.74e-06	0.000213	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PIK3CA—uterine cancer	1.73e-06	0.000212	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—AKT1—uterine cancer	1.67e-06	0.000205	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TP53—uterine cancer	1.67e-06	0.000205	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—HRAS—uterine cancer	1.6e-06	0.000196	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—MTHFR—uterine cancer	1.52e-06	0.000187	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—AKT1—uterine cancer	1.45e-06	0.000178	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—AKT1—uterine cancer	1.41e-06	0.000173	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PIK3CA—uterine cancer	1.28e-06	0.000158	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—AKT1—uterine cancer	1.05e-06	0.000129	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PTEN—uterine cancer	8.47e-07	0.000104	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—EP300—uterine cancer	8.07e-07	9.9e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PIK3CA—uterine cancer	5.97e-07	7.33e-05	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—AKT1—uterine cancer	4.88e-07	5.98e-05	CbGpPWpGaD
